CHEST-2 and PATENT-2 are supported by Bayer Healthcare, maker of riociguat. Dr. Simonneau and Dr. Lewis reported financial relationships with several drug companies including Bayer.
Conference Coverage
Riociguat benefits persist in pulmonary hypertension
Publish date: November 27, 2013
AT CHEST 2013